Davis's Drug Guide

anistreplase

Contraindication/Precautions

Contraindicated in:

• Active internal bleeding

• History of cerebrovascular accident

• Recent (within 2 months) intracranial or intraspinal injury or trauma

• Intracranial neoplasm, arteriovenous malformation, or aneurysm

• Severe uncontrolled hypertension

• Known bleeding tendencies

• Hypersensitivity; cross-sensitivity with anistreplase and streptokinase may occur



Use Cautiously in:

• Recent (within 10 days) major surgery, trauma, GI or GU bleeding

• Left heart thrombus

• Severe hepatic or renal disease

• Hemorrhagic ophthalmic conditions

• Septic phlebitis

• Previous puncture of a noncompressible vessel

• Subacute bacterial endocarditis or acute pericarditis

• Recent streptococcal infection or previous therapy with anistreplase or streptokinase (within 5 days–6 mo); may produce resistance because of antibody formation; increased dosage requirements may be encountered (anistreplase and streptokinase only)

• Previous therapy with streptokinase or anistreplase (within 12 months); may produce resistance because of antibody formation

OB: Lactation: Pedi: Safety not established

Geri: Increased risk of intracranial bleeding



Exercise Extreme Caution in:

• Patients receiving warfarin therapy

OB: Early postpartum period (10 days)



anistreplase is a sample topic found in Davis's Drug Guide. All other sections of this record are viewable by clicking on the index in the left column, or by clicking on "Display all Sections" in the "Content Manager".

To find other Davis's Drug Guide topics, please login or purchase a subscription.

Content Manager
Search Unbound MEDLINE
Display all Sections
Font Size
PrintSectionTopic
Related Content
streptokinase